Man sentenced for selling fake Viagra from China; Boehringer Ingelheim fined over waste issues;

> A Puerto Rico man who bought counterfeit Viagra and Cialis from China and resold it in the U.S. has been sentenced to 21 months in prison. Release

> Mark Walchirk has been named president of McKesson U.S. Pharmaceutical, the company's drug wholesaling operation, which is its largest division. Item

> With the help of some incentives from Virginia, McKesson will build a $37 million facility in Frederick County from which it will distribute medical and surgical supplies. Story

> The FDA has sent a warning letter to Mark's Marine Pharmacy in British Columbia, Canada, telling it to quit offering to sell to U.S. doctors clobazam, a controlled substance that it says only Lundbeck is approved to sell. Warning letter

> Boehringer Ingelheim's veterinary medicine division will pay a $68,000 fine and spend at least $300,000 to upgrade a hazardous waste storage facility in St. Joseph, MO, after being cited for mishandling mercury produced in its animal vaccine process. Story

> A Chinese company that makes most veterinary products has been sent an FDA warning letter for failing to register and therefore marketing unapproved drugs in the U.S. Warning letter

And Finally... Alchem International is expanding the production of sennoside used in laxatives at a plant in Neemrana, Rajasthan, India. Item

Suggested Articles

Neopharma, which has been buying and building plants for several years, is buying a sterile injectables plant and assets in Japan from India’s Lupin. 

Already knocked by the FDA four times this year, Dr. Reddy’s now has a fifth Form 483 to dwell on. This time it’s at a plant with a history of faults.

In a warning letter, the FDA details how a Chinese OTC drugmaker handed over documents faked just for the agency's inspection—and admitted it.